Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
New York City Mayor De Blasio Backs Marijuana Legalization, Days After Governor Cuomo Does So
https://www.marijuanamoment.net/new-york-city-mayor-de-blasio-backs-marijuana-legalization-days-after-governor-cuomo-does-so/
Santa needs to come down the chimney first before he drops our presents .
But It looks like a very tall chimney ..
Again, English not being my mother tongue I am not the right person to talk about semantic but why not say "in the next few days or weeks" since this year ends in 21 days?
we’ll be putting forward a Notice of Proposed Rulemaking some point this year to regulate nicotine levels in combustible cigarettes…
More U.S. Teens Are Vaping, But Use of opioids and alcohol falls
https://consumer.healthday.com/cancer-information-5/electronic-cigarettes-970/more-u-s-teens-are-vaping-but-use-of-opioids-alcohol-falls-740634.html
It’s true! The Senate will take up a vote on the #FarmBill this afternoon. I urge my colleagues to come together and support this bill so we can provide our nation’s farmers, ranchers, rural communities, and tribes with certainty and predictability.
It’s true! The Senate will take up a vote on the #FarmBill this afternoon. I urge my colleagues to come together and support this bill so we can provide our nation’s farmers, ranchers, rural communities, and tribes with certainty and predictability. https://t.co/7D2CfvvPpM
— Senator Tina Smith (@SenTinaSmith) December 11, 2018
2 Excellent Videos on Hemp-CBD Market After Legalization
Smoke a joint and save the subway?
I am all for it!
Money from marijuana legalization could fix MTA
https://nypost.com/2018/12/05/money-from-marijuana-legalization-could-fix-mta-report/
Deal talks flying in beverage-cannabis-tobacco realm
Dec. 3, 2018 2:26 PM ET|By: Clark Schultz, SA News Editor
There's a lot of discussions going on between both beverage and tobacco giants with cannabis players, according to Financial Times.
Following up on news from earlier today that Altria (MO +1.4%) is in early talks about a takeover of Cronos Group (CRON +10.7%), FT says Coca-Cola (KO -1.9%) has held talks with Canada’s Aurora Cannabis (ACB +0.5%) to develop beverages and Diageo (DEO -0.1%) is sniffing around the sector.
FT also tips that Altria has held talks with Tilray (TLRY +0.9%) and Aphria (APHA -23.4%) in addition to the Cronos interest.
Constellation Brands (STZ +0.4%) started off the beverage-cannabis wave earlier this year when it invested just under $4B in Canopy Growth (CGC +0.1%).
U.S. Farm Bill Legalizing Hemp Expected to be Finalized This Week or by the End of the Year
On Thursday, an agreement in principle was reached by the House and Senate farm bill negotiators, which multiple sources confirmed will include provisions to federally legalize hemp. When passed, the bill will allow states to regulate hemp, as well as allow hemp researchers to apply for grants from the Department of Agriculture and make hemp farmers eligible for crop insurance.
Senate Majority Leader Mitch McConnell (R-Ky.) initially introduced the Hemp Farming Act of 2018 in the Senate's version of the farm bill including provisions to legalize hemp and remove it from the federal list of controlled substances.
"This is an incredibly exciting time to be on the forefront of the hemp industry," said Hemp, Inc. CEO Bruce Perlowin. "We have already had multiple confirmations that provisions for hemp will be included in the final version of the bill, and now it is just a matter of days before it is passed, based on what we are currently reading. We are thrilled for the opportunities this bill will open up for Hemp, Inc. to partner with farmers across the nation and be able to offer them hemp processing services and to build out our network of interstate commerce and trade. We are thrilled with the success our Local Processing Center model has already seen in Southern Oregon and trust that this legislation will encourage many other local farmers across the nation to make the switch to hemp for a stable, sustainable and profitable future."
I guess the FDA will do what it has to do
and I see Altria positioning itself for the future...whatever that is.
They want to dominate everything!
I don't usually follow BT stocks, but lately yes so today I found this news
Why A Deal Between Altria And Aphria Makes Sense
Oct. 29, 2018
Summary
Altria is reportedly talking with Aphria for a minority investment in the Canadian cannabis company.
Altria has made similar deals outside its tobacco business including its existing 10% interest in beer giant AB InBev.
Aphria appears to be the logical partner given its appealing valuation and industry-leading capabilities in production and market access.
We are optimistic that a deal could be reached given the logical strategic merits for both firms assuming final terms could be agreed upon.
Altria (MO), one of the world's largest tobacco company, was reported by Globe and Mail that it is in talks to acquire a minority stake in Aphria (APHQF), one of the leading Canadian cannabis firm and one of our recent top picks. It is no surprise that Altria is looking to get into cannabis, as we will decipher for you below, and why Aphria makes the most sense for a minority investment. We think the possibility of the deal is high and there remains upside in Aphria's share price should this transaction proceed as reported.
Situation Overview
On June 28, we published our article "Aphria: A Molson Coors Investment Could Be The Catalyst It Needs" in which we made the following conclusion:
Aphria is just a much cleaner story operationally and we think they have a higher chance of being selected by Molson which...
https://seekingalpha.com/article/4211109-aphria-altria-big-tobacco-enters-cannabis-industry
I use seeking Alpha but not as a subscriber so can't get the all article
Pot patents
I guess will be the new wild west!
Cannabis Extract Patent Assertion Underscores Issue of Limited Prior Art for Marijuana Inventions
https://www.ipwatchdog.com/2018/08/07/cannabis-patent-assertion-underscores-issue-limited-prior-art-marijuana-inventions/id=99980/
So after this I think XXII is still the right stock to be IN and we don't have to worry about it ,VLN WILL happen there is room for all of us!
Guys (Brooklyn and Esad)
I think we have it all wrong, my initial thought was the same, WTF? Why would Altria invest in a cigarette vaping company? After the FDA is explicitly banning flavored nicotine pods??
Juul is a vaping company, vaping is a delivery system, you can deliver nicotine or you can deliver THC if smoking marijuana (a friend of mine use a vaping device for smoking MJ so I know!)
So I think Altria is looking at a world post nicotine and is getting into the delivery system for now then into cannabis later either in partnering with a company in Canada Or waiting later for the legalization here in the US.
Marijuana is already huge and will complement nicely or replace the $$$ lost in their cigarettes sale.
Altria has been struggling with cigarettes sale and the stock lost $25 since January
I think it’s a smart play by Altria to buy into Juul (a brand name so recognizable "Juuling" has become synonymous with vaping"
And like Esad said but in regards to xxii “a much smarter way to hedge their future”
Would love to know how much $$ they are spending on this minority stake ?
What do you think?
What's going on here????
Altria is reportedly in talks to take a minority stake in Juul
Altria is in talks to take a significant minority stake e-cigarette company Juul, the Wall Street Journal reported on Wednesday.
Altria is in talks to take a significant minority stake in e-cigarette company Juul, the Wall Street Journal reported on Wednesday.
Any deal is likely several weeks away, the Wall Street Journal reported.
This story is developing. Please check back for updates.
https://www.cnbc.com/2018/11/28/altria-is-reportedly-in-talks-to-take-a-minority-stake-in-juul.html
Why wouldn't you want to own us there knowing what may be coming down the pike. In marijuana and hemp for a bonus.
Could XXII be broken up in 3 divisions ? Tobacco, marijuana and Hemp
And make deal with different companies for each division?
Do you see that happening?
OT Here's what's behind Mexico's radical move toward legalizing marijuana during its war on drugs
https://www.latimes.com/world/mexico-americas/la-fg-mexico-marijuana-2018-story.html
How Long Before The FDA Could Ban Menthol Cigarettes?
Today 11:43 AM ET (Benzinga)Print
Earlier this month, the U.S. Food & Drug Administration announced its latest efforts to restrict tobacco companies marketing to teens. Tobacco investors are watching closely to see how the FDA plans to attack and how the industry will respond.
Latest From The FDA
On Nov. 15, FDA head and cancer survivor Scott Gottlieb announced new restrictions on flavored vaping products. However, Gottlieb got tobacco investors’ attention by also proposing an outright ban on menthol cigarettes, which represent about 35 percent of total U.S. cigarette sales.
Anti-tobacco organization Truth Initiative said the FDA should implement its ban immediately on menthol cigarettes immediately and warned the regulatory process can be extremely slow.
“Banning menthol cigarettes and all flavored cigars is one of the most powerful actions the FDA can take when it comes to saving lives,” Truth Initiative said in a statement.
Actions Louder Than Words
While a ban on menthol cigarettes is a major potential disruptor for the tobacco industry, Height Capital Markets said this week Gottlieb’s bark has been louder than his bite up to this point.
“Since his November 15 announcement, we have yet to see the agency formally advance the regulatory process required to ban menthol cigarettes,” Height wrote.
“The FDA has not issued a notice of proposed rulemaking (NPRM), and inaction by the FDA combined with press reports now makes it seem like this event will not occur until 2019,” Height said.
Height said an NPRM submitted by the end of January 2019 could still put the ban on track to be implemented by the end of 2020, but any delays beyond January could push the ban back to 2021.
Stocks Impacted
According to Wells Fargo, British American Tobacco PLC (NYSE: BTI) would potentially take the biggest hit from a menthol ban, with about 55 percent of its U.S. volume coming from menthol sales. Altria Group Inc (NYSE: MO) (21 percent of volume) and Imperial Tobacco Group plc (OTC: IMBBY) (20 percent of volume) would also be impacted.
If Height’s projections are correct,
Philip Morris International Inc (NYSE: PM) and 22nd Century Group, Inc. (NYSE: XXII) would also have about two years to prepare for a potential menthol ban.
..This last paragraph is confusing at best...
OK but could the Canadian government mandate that ALL cigarettes sold in Canada be VLN? just wondering if it is possible
Ok if not hemp and marijuana How about a deal on VLN Tobacco in canada?
Poignant story on the NY Times today
Here is the full story
The Price of Cool: A Teenager, a Juul and Nicotine Addiction
E-cigarettes may help tobacco smokers quit. But the alluring devices can swiftly induce a nicotine habit in teenagers who never smoked. This is the tale of one person’s struggle.
Nov. 16, 2018
226
READING, Mass. — He was supposed to inhale on something that looked like a flash drive and threw off just a wisp of a cloud? What was the point?
A skeptical Matt Murphy saw his first Juul at a high school party in the summer of 2016, in a suburban basement crowded with kids shouting over hip-hop and swigging from Poland Spring water bottles filled with bottom-shelf vodka, followed by Diet Coke chasers.
Everyone knew better than to smoke cigarettes. But a few were amusing themselves by blowing voluptuous clouds with clunky vapes that had been around since middle school. This Juul looked puny in comparison. Just try it, his friend urged. It’s awesome.
Matt, 17, drew a pleasing, minty moistness into his mouth. Then he held it, kicked it to the back of his throat and let it balloon his lungs. Blinking in astonishment at the euphoric power-punch of the nicotine, he felt it — what he would later refer to as “the head rush.”
“It was love at first puff,” said Matt, now 19.
The next day, he asked to hit his friend’s Juul again. And the next and the next. He began seeking it out wherever he could, that irresistible feeling — three, sometimes four hits a day.
So began a toxic relationship with an e-cigarette that would, over the next two years, develop into a painful nicotine addiction that drained his savings, left him feeling winded when he played hockey and tennis, put him at snappish odds with friends who always wanted to mooch off his Juul and culminated in a shouting, tearful confrontation with his parents.
He would come to hate himself for being dependent on the tiny device, which he nicknamed his “11th finger.” Yet any thought of quitting made him crazy-anxious.
Experiences like Matt’s have placed Juul at the epicenter of a national debate. On one side stand longtime adult smokers who celebrate the device as the aid that finally helped them quit smoking. On the other are teenagers who have never smoked a cigarette but who have swiftly become addicted to Juul’s intense nicotine hits.
This week the Food and Drug Administration tried to walk a careful line between the two, announcing restrictions that only permit stores to sell most flavored e-cigarettes from closed-off areas that are inaccessible to customers under 18. But it stopped short of previous threats to ban stores from selling flavors altogether.
The agency has acknowledged that it was caught flat-footed by a tidal wave of teenage vaping. According to the 2018 National Youth Tobacco Survey, released this week, the number of middle and high school students who currently vape has soared to about 3.6 million. On Dec. 5, the F.D.A. will hold a public hearing about potential therapies to address teenage nicotine addiction.
The easily concealable Juul, which had barely come on the market when Matt tried it, has become wildly popular with teenagers and now accounts for more than 70 percent of the e-cigarette sales in the United States. The F.D.A. is investigating whether the company that makes it, Juul Labs, intentionally marketed its devices to youth. On Tuesday, under increasing pressure, Juul announced it would stop its social media promotions and suspend store sales of many of its flavors — except for tobacco, menthol and mint (Matt’s favorite).
One pod, or cartridge, of Juul’s flavored liquids contains an amount of nicotine roughly equivalent to a pack of cigarettes. That can be a benefit to smokers who get the nicotine fix they desperately seek without the carcinogenic smoke that comes from burning tar-laden tobacco. But the impact on teenagers, whose brains are still developing, is troubling.
“Nicotine may disrupt the formation of circuits in the brain that control attention and learning,” said Dr. Rachel Boykan, a clinical associate professor of pediatrics at Stony Brook University School of Medicine and an executive member of the American Academy of Pediatrics’ section on tobacco control. “And there is a higher risk of them subsequently becoming tobacco smokers.”
The science about long-term effects of the other chemicals and small metals in the vaporized liquids is unsettled, not only because formulations vary widely and are often undisclosed, but because e-cigarettes have not been around long enough to study thoroughly.
Some research suggests disturbing risks. A joint project between Duke and Yale’s Tobacco Center of Regulatory Science, published this fall in the journal Nicotine and Tobacco Research, found that when certain popular flavors are added to a common solvent in the vaping liquids, they produce chemicals that irritate airways and lungs. A 2016 study in the journal Chest said that smoking e-cigarettes had an effect on the heart and arteries which, while was not as pronounced as that of combustible cigarettes, was still distinctive.
Perhaps what alarms public health experts most about e-cigarettes generally and Juul in particular is nicotine which, when vaporized, is absorbed by the body within seconds, much faster than when delivered by chewing gum or patches. Its potent addictive properties, doctors say, can be most pronounced in teenagers.
******
After a few weeks of bumming daily hits from friends (called “fiending”), Matt went on a family vacation out West. On his second day without a Juul, he found he wanted one desperately. On the third, he couldn’t take it anymore.
He searched Juul’s website to find a local store that sold it, and ordered an Uber to get there, mumbling a nonchalant excuse to relatives. Between the cost of the ride service plus the Juul “starter” kit, he spent $100 to sate his need.
Soon, he escalated to a daily pod, sometimes more. He was spending $40 a week, draining his Christmas and birthday money, and his paycheck from his part-time job at Chili’s.
Matt doesn’t come across as a cool alpha. He’s an easy, approachable kid with a certain sweetness, voted “best personality” by his high school classmates. Focused on achieving academic and financial success, he stayed away from marijuana, alcohol and cigarettes. The Juul, he thought, was a harmless way to look like an edgy risk-taker.
It became stitched into his social identity, and bound him to his buddies, who would ride around town hitting their Juuls in one friend’s 2002 Volvo. By the time he graduated from high school in 2017, four of his five closest friends were also daily Juulers.
He and other athletes noticed they would get out of breath more quickly. “We called it ‘Juul lung,’ ” Matt said. “We knew it lowered our performance but we saw that as a sacrifice we were willing to make.”
There is an art and artifice to being a teenage Juuler, Matt explained during numerous long conversations, including one over a recent lunch at a local pizza shop. You have to scope out which convenience stores will card you and which will look away, so long as you pay their inflated prices.
Near Matt’s house in Reading, a middle-class Boston suburb, there are two convenience stores on West Street. The first won’t sell you e-cigarettes unless you are 21. The second was just over the town line in neighboring Woburn, where the legal age until recently was 18. Turned away in Reading, Matt and his friends would simply saunter down the block, where they could pass scrutiny.
What he had initially derided as Juul’s pitiful wisp of nearly odor-free vapor turned out to be a great advantage. Teachers were clueless. If his parents walked into his room five seconds after he exhaled, they wouldn’t know. “The Juul was super, super sneaky and I loved it,” he said.
But by the time he got to college, he began to admit to himself he had a problem. He was majoring in biochemistry at the University of Vermont and feeling overwhelmed by the workload; the Juul was his only stress-escape. To limit his use, he kept it in his dorm room rather than carry it with him.
But soon, he realized: “All I wanted was to be in my room.”
He had 40 minutes between classes: Ten minutes, bike to the dorm. Hit Juul, 20 minutes. Ten minutes, bike to next class. Repeat.
[Like the Science Times page on Facebook. | Sign up for the Science Times newsletter.]
By now his vaping was about maintenance, keeping the craving irritability at bay. He knew things had gotten just ridiculous, but there was nothing to be done about it. He even fixed a Velcro strip on the dresser next to his dorm room bed and stuck the Juul on it, so that as soon as he opened his eyes in the morning he could just reach up for a hit: first, best, only head rush of the day.
One girl on his dorm hall sold Juul pods from stock she had bought from a guy who ordered armloads on the internet. Unlike back home in high school, college students vaped in public everywhere — in lecture halls, at hockey games, in the dorm common rooms.
“Matt was open about wishing he didn’t do it,” said Tucker Houston, his freshman roommate. “It was a constant battle for him. People would tell him that they’d want to buy a Juul and he’d be like, ‘No! You don’t want to, it’s not cool, it’s not fun.’ He became known as the juuling anti-Juul advocate.”
This past summer, Matt returned home to work construction for his father, a building contractor. In the full sway of his addiction, he stuck the empty pods in his backpack so they wouldn’t be spotted in the household trash. He hid the Juul in his bedroom, doing without it on the job for up to six hours at a stretch.
That was rough.
“But I knew if my parents caught me, I couldn’t do it again, and that represented a future of not doing it,” Matt said. “I rationalized that it was better to do without it briefly, than forever.”
Then he found that the delayed gratification from leaving it at home was fantastic. “If you wait an hour, it feels great. But if you wait five hours, it feels unbelievable.”
At the end of the day, he would take a long, two-second draw, and keep it in his lungs, a practice called “zeroing,” because his body absorbed all the vapor, exhaling none. He’d zero it four or five times, feel dizzy, blink about 10 times, and then be fine.
One day, Matt’s mother walked into his room to collect his dirty laundry. There was his backpack, unzipped, open.
The confrontation with his parents was epic.
David Murphy, Matt’s father, was startled by the extent of Matt’s Juul concealment. He hadn’t suspected something was amiss. Matt’s behavior never seemed appreciably altered.
The vaping had to end, Mr. Murphy ordered. “I said, ‘Nicotine is a lifelong burden. There’s a big company with its hand in your pocket, distracting your thought process continuously. Juuling is a huge undocumented risk. Now, how do we come back together as a family and solve this problem?”
Two hours into the tearful conversation, Matt concluded: “I could not justify the addiction anymore. And I realized my parents were my allies. Because I wanted to stop and they wanted me to stop.”
Because Juul is so new, there is no consensus protocol for how teenagers should withdraw. Matt devised a weaning regimen: every two hours, five short hits. Then longer breaks, fewer hits.
One June day he was riding shotgun in the Volvo with his old friends. As he was about to take a scheduled hit, he grew despairing and exasperated. He had tried quitting before but it had never worked; would he always be chained to this gadget? Impulsively, he tried to throw the Juul out the car window, but the window stuck. So he abruptly yanked back the sunroof and heaved it to the street.
One friend, sitting in the back, cheered and pumped his fist. But another scowled — he would happily have taken Matt’s Juul.
“I felt strong for five minutes,” Matt said. “And then I felt really weak. I only realized the magnitude of my addiction when I stopped.”
Nicotine withdrawal, he said, was hell. He was overtaken with bouts of anxiety. Who was he without his 11th finger? He would get the shakes, curl up in his bed, overcome with a sense of powerlessness.
“When Matt withdrew, he’d flip out a lot, especially when other people had it around him,” said Jared Stack, a friend since elementary school. “They wouldn’t stop doing it just because he had. They didn’t care — because they were addicted too.”
it was the whirring, the purring, the sound of their Juuls firing up, that would trigger Matt. Yet avoiding his friends was inconceivable.
After three weeks, the worst of it passed. Even still, Matt can tick off to the day how long it’s been since he stopped on June 6: 163 days as of Friday.
He transferred to the University of Massachusetts in Lowell, majoring in business and living at home. Whenever he feels the Juul urge now, he tells himself, “I’d have to go through the whole horrible dark time that is being addicted and then quitting.”
His eyes brightened as he gulped the last of his pizza, long limbs splayed everywhere. Instead, he said, he tries to help friends who want to quit. “They text me all the time when they’re trying. They’ll say, ‘Did you experience this?’
“And I say, ‘Yes,’ because I want them to know I understand,” he said. “And then I tell them, ‘But it gets better.’ Because it does.”
Poignant story on the NY Times today
The Price of Cool: A Teenager, a Juul and Nicotine Addiction
E-cigarettes may help tobacco smokers quit. But the alluring devices can swiftly induce a nicotine habit in teenagers who never smoked. This is the tale of one person’s struggle.
https://www.nytimes.com/2018/11/16/health/vaping-juul-teens-addiction-nicotine.html
FDA announces sweeping anti-smoking measures to target teen vaping
Sale of sweet-flavored e-cigarettes to be severely restricted
Ban on menthol cigarettes also planned
https://www.theguardian.com/society/2018/nov/15/fda-announces-sweeping-anti-smoking-measures-to-target-teen-vaping
It has been talked about non stop this past week !
Wells Fargo calls Philip Morris a top pick
Nov. 14, 2018 7:53 AM ET|About: Philip Morris Internation... (PM)|By: Clark Schultz, SA News Editor
Wells Fargo names Philip Morris International (NYSE:PM) as its top sector pick and recommends the stock to investors as a core holding in 2019.
"We believe PM has reached an inflection point and the set up heading into 2019 is even more positive than we originally thought," writes analyst Bonnie Herzog.
Positive trends in PM's core cigarette business and movement with the IQOS business are cited as positive factors.
WF reiterates its Outperform rating on Philip Morris and price target of $100.
$86 as we speak...Let's see where PM is in 2019 and where XXII is.
Maybe after all PM needs the xtra $$ to pay XXII royalties or buy us over!! LOL
Bragar Eagel & Squire, P.C.
885 Third Avenue, Suite 3040
New York, New York 10022
This huge building is filled with offices (suites) and yes like any big office building in NYC the ground floor is reserved for retail spaces ( Hint the lipstick restaurant) ...Just saying....
Long XXII
Very interesting.....
The Feds Want Researchers To Study ‘Minor’ Cannabinoids And Terpenes In Marijuana
Published November 12, 2018
Tetrahydrocannabinol (THC)—the marijuana compound known for getting you high—is the most well-know cannabis constituent. In recent years, cannabidiol (CBD) has garnered attention for its non-intoxicating medicinal properties.
Now, the federal government is recruiting researchers to investigate how the dozens of other lesser-known cannabinoids and terpenes work and whether they can treat pain.
It’s going to be a weighty task for any interested parties. There are more than 110 known cannabinoids and 120 terpenes, very few of which have been extensively studied. The federal research project will cover all “minor cannabinoids,” which is defined as anything other than THC, according to a pair of funding notices published by the National Center for Complementary and Integrative Health this week.
“The mechanisms and processes underlying potential contribution of minor cannabinoids and terpenes to pain relief and functional restoration in patients with different pain conditions may be very broad,” the notices state. “This initiative encourages interdisciplinary collaborations by experts from multiple fields—pharmacologists, chemists, physicists, physiologists, neuroscientists, psychologists, endocrinologists, immunologists, geneticists, behavioral scientists, clinicians, and others in relevant fields of inquiry.”
Numerous studies have established that ingredients in marijuana such as THC and CBD effectively treat various types of pain. There’s also some evidence that other cannabinoids and terpenes contribute to the therapeutic efficacy of cannabis, working synergistically to bolster the plant’s overall benefits—a phenomenon called the “entourage effect.”
But there’s still a lot of work to be done to fully understand the mechanisms through which each cannabinoid and terpene influences pain. If researchers can pinpoint which ingredients are best suited for pain relief, it could inform new therapies. For example, there’s evidence that certain cannabinoids can enhance the pain-relieving effects of opioids, the notice states, so discovering exactly which ones achieve that end can hypothetically help patients take lower doses of addictive painkillers.
“The development or identification of novel pain management strategies is a high priority and unmet need. Natural products have historically been a source of novel analgesic compounds developed into pharmaceuticals (e.g., willow bark to aspirin). A growing body of literature suggests that the cannabis plant may have analgesic properties; however, research into cannabis’s potential analgesic properties has been slow.”
In addition to CBD, the feds say they are particularly interested in research on the following compounds: cannabigerol (CBG), cannabinol (CBN), cannabichromene (CBC), myrcene, ß-caryophyllene, limonene, a-terpineol, linalool, a-phellandrene, a-pinene, ß-pinene, terpinene and a-humulene.
The estimated deadline to submit an application for research funding is March 8, 2019.
https://www.marijuanamoment.net/the-feds-want-researchers-to-study-minor-cannabinoids-and-terpenes-in-marijuana/